CH647481A5 - Solutions concentrees stables de cisplastine dans un solvant. - Google Patents

Solutions concentrees stables de cisplastine dans un solvant. Download PDF

Info

Publication number
CH647481A5
CH647481A5 CH2023/81A CH202381A CH647481A5 CH 647481 A5 CH647481 A5 CH 647481A5 CH 2023/81 A CH2023/81 A CH 2023/81A CH 202381 A CH202381 A CH 202381A CH 647481 A5 CH647481 A5 CH 647481A5
Authority
CH
Switzerland
Prior art keywords
cisplatin
solution
weight
polyethylene glycol
solutions
Prior art date
Application number
CH2023/81A
Other languages
English (en)
French (fr)
Inventor
Murray Arthur Kaplan
Alphonse Peter Granatek
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of CH647481A5 publication Critical patent/CH647481A5/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH2023/81A 1980-03-31 1981-03-25 Solutions concentrees stables de cisplastine dans un solvant. CH647481A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (1)

Publication Number Publication Date
CH647481A5 true CH647481A5 (fr) 1985-01-31

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2023/81A CH647481A5 (fr) 1980-03-31 1981-03-25 Solutions concentrees stables de cisplastine dans un solvant.

Country Status (30)

Country Link
JP (1) JPS56152415A (it)
KR (1) KR860000841B1 (it)
AR (1) AR225500A1 (it)
AT (1) AT370996B (it)
AU (1) AU541056B2 (it)
BE (1) BE888209A (it)
CA (1) CA1162479A (it)
CH (1) CH647481A5 (it)
CS (1) CS246051B2 (it)
DD (1) DD157762A5 (it)
DE (1) DE3112272A1 (it)
DK (1) DK158564C (it)
ES (1) ES500869A0 (it)
FI (1) FI70670C (it)
FR (1) FR2480605A1 (it)
GB (1) GB2074028B (it)
GR (1) GR72769B (it)
HU (1) HU183379B (it)
IE (1) IE51070B1 (it)
IL (1) IL62517A (it)
IT (1) IT1170838B (it)
LU (1) LU83270A1 (it)
NL (1) NL8101531A (it)
NO (1) NO156675C (it)
NZ (1) NZ196519A (it)
PH (1) PH17152A (it)
PT (1) PT72774B (it)
SE (1) SE455045B (it)
SU (1) SU1056893A3 (it)
ZA (1) ZA812084B (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
FR2480605B1 (it) 1984-05-11
DE3112272C2 (it) 1990-09-27
AR225500A1 (es) 1982-03-31
DK144281A (da) 1981-10-01
DD157762A5 (de) 1982-12-08
JPS6360008B2 (it) 1988-11-22
DK158564C (da) 1990-11-05
IE51070B1 (en) 1986-09-17
NZ196519A (en) 1983-06-17
IE810715L (en) 1981-09-30
IL62517A (en) 1984-01-31
SU1056893A3 (ru) 1983-11-23
CA1162479A (en) 1984-02-21
DK158564B (da) 1990-06-11
ES8206545A1 (es) 1982-08-16
IL62517A0 (en) 1981-05-20
AU6816681A (en) 1981-10-08
AT370996B (de) 1983-05-25
HU183379B (en) 1984-04-28
PT72774B (en) 1982-11-16
DE3112272A1 (de) 1982-04-29
PT72774A (en) 1981-04-01
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
NO156675C (no) 1987-11-04
JPS56152415A (en) 1981-11-26
FI810934L (fi) 1981-10-01
KR830004849A (ko) 1983-07-20
FR2480605A1 (fr) 1981-10-23
PH17152A (en) 1984-06-13
ATA150481A (de) 1982-10-15
IT8148090A0 (it) 1981-03-24
FI70670C (fi) 1986-10-06
CS246051B2 (en) 1986-10-16
FI70670B (fi) 1986-06-26
IT1170838B (it) 1987-06-03
NL8101531A (nl) 1981-10-16
AU541056B2 (en) 1984-12-13
LU83270A1 (fr) 1981-10-29
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
GR72769B (it) 1983-12-02
SE8101990L (sv) 1981-11-13
ES500869A0 (es) 1982-08-16
NO811081L (no) 1981-10-01

Similar Documents

Publication Publication Date Title
US4451447A (en) Pharmaceutical formulations
FR2511357A1 (fr) Cis-platine microcristallin, son procede de preparation et composition pharmaceutique le contenant
FR2751875A1 (fr) Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
MXPA04005423A (es) Formulaciones farmaceuticas con derivado de platino.
WO2012094033A1 (en) Methods of making liposomes, liposome compositions made by the methods, and methods of using the same
CH647481A5 (fr) Solutions concentrees stables de cisplastine dans un solvant.
JP2003521518A (ja) モノチオグリセロール、ｌ−システインまたはチオグリコール酸とともにペメトレクストを含む医薬組成物
EA003864B1 (ru) КОМПОЗИЦИЯ И СПОСОБ ПРИГОТОВЛЕНИЯ ФАРМАЦЕВТИЧЕСКОГО СОСТАВА, ЛИОФИЛИЗИРОВАННАЯ КОМПОЗИЦИЯ И ЕЕ ПРИМЕНЕНИЕ, СПОСОБ ИНГИБИРОВАНИЯ sPLA2-ОПОСРЕДОВАННОГО ВЫСВОБОЖДЕНИЯ ЖИРНОЙ КИСЛОТЫ, СПОСОБ ЛЕЧЕНИЯ МЛЕКОПИТАЮЩИХ, СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ СЕПСИСА, ЗАКРЫТАЯ ЕМКОСТЬ
US3993639A (en) Heptaminol adenosine-5'-monophosphate
JP2001515874A (ja) モノヒドロキサム酸塩のバナジウム錯体及び当該錯体で構成される医薬品組成物
OA13348A (fr) Composition pharmaceutique de vinflunine destinée à une administration parentérale, procédé de préparation et utilisation.
CN103191119A (zh) 伊曲康唑抑制Akt激酶活性的用途
CN102335114A (zh) 一种稳定的布洛芬精氨酸注射剂及其制备方法
FR2619313A1 (fr) Nouvelles compositions d'elements mineraux et/ou oligoelements et leur procede de preparation
CN101129374B (zh) 长春氟宁药物组合物及其制备方法与应用
AU669909B2 (en) Veterinary rehydration product
US4946689A (en) Concentrated, stabilized cis-diamminedinitratoplatinum solutions for conversion to cisplatin
JPH09328425A (ja) アポトーシス調節剤
RU2815979C1 (ru) Интраназальная композиция, содержащая соединения полидигидроксифенилентиосульфоната натрия (ПДФН) и L-триптофан, и способ получения композиции.
JP2003513034A (ja) 骨髄もしくは血液幹細胞の移植前の患者のコンディショニングのためのトレオスルファンの使用
JPH05178716A (ja) アズレン誘導体
FI72302C (fi) Foerfarande foer framstaellning av stabilt mikrokristallint cisplatin.
JPH03157385A (ja) 細胞防護剤
JPH03206033A (ja) 抗白せん菌剤
DK157484B (da) Fremgangsmaade til fremstilling af et cisplatin-praeparat

Legal Events

Date Code Title Description
PL Patent ceased